HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS (HIV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS (HIV) trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New peer support program aims to cut substance use and HIV risk in transgender community
Disease control Recruiting nowThis study is testing a new mutual-help group called the TLC Program for transgender adults who use substances or are recently in recovery. The program uses mindfulness and values-based counseling to improve mental health and reduce HIV risk. Researchers will enroll 124 participa…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Illinois Institute of Technology • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
New study aims to help smokers with HIV kick the habit for good
Disease control Recruiting nowThis study tests a smoking cessation program designed for people living with HIV who smoke at least 5 cigarettes a day. The goal is to find a cost-effective and sustainable way to help them quit, using methods like nicotine replacement therapy and counseling. About 500 participan…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE4 • Sponsor: New York University • Aim: Disease control
Last updated May 26, 2026 05:29 UTC
-
Heart attack shield? HIV drug combo trial aims to slash plaque
Disease control Recruiting nowThis study tests whether adding a drug called fostemsavir to standard HIV treatment can lower heart disease risk. People with well-controlled HIV and at least one heart risk factor (like smoking or high blood pressure) will get either the extra drug or usual care. Researchers wil…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated May 26, 2026 05:20 UTC
-
Can an app help HIV patients kick the habit? new study seeks answers.
Disease control Recruiting nowThis study compares two smartphone apps designed to help people living with HIV quit smoking. About 314 participants will use one of the apps for 24 weeks, along with nicotine patches and gum. The goal is to see which app works better at helping people stay smoke-free, with regul…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
HIV prevention boost: 30,000 people in kenya to get PrEP through family planning clinics
Prevention Recruiting nowThis study tests a new way to deliver HIV prevention medicine (PrEP) by having HIV testing counselors lead PrEP care in family planning clinics in Kenya. About 30,000 people aged 15 and older who visit these clinics will take part. The goal is to see if this approach helps more p…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated May 26, 2026 05:31 UTC
-
Monthly pill could replace daily HIV prevention
Prevention Recruiting nowThis study tests a new once-monthly pill (MK-8527) to see if it works as well as the standard daily pill for preventing HIV-1 infection. About 4,390 HIV-negative adults who are at risk of HIV will take either the monthly pill or a daily pill for up to 18 months. Researchers will …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 26, 2026 05:25 UTC
-
Monthly pill could revolutionize HIV prevention for women
Prevention Recruiting nowThis study tests a new monthly pill (MK-8527) to see if it works better than a daily pill for preventing HIV in women. About 4,580 HIV-negative women who are sexually active will take either the monthly pill or a daily standard PrEP pill. The goal is to find a simpler, effective …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
Spinal adjustments for HIV? new study tests Chiropractic's impact on inflammation and Well-Being
Symptom relief Recruiting nowThis pilot study is testing whether chiropractic care can improve quality of life and reduce inflammation in adults with HIV. Researchers will compare a group receiving weekly chiropractic adjustments to a group receiving no treatment. The study aims to see if a larger trial is p…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Tyson Perez, DC, PhD • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC
-
HIV testing habits under the microscope: 1,000 volunteers sought
Knowledge-focused Recruiting nowThis study is looking at how adults in France choose to get tested for HIV. Researchers will ask 1,000 volunteers which testing method they used, such as a doctor's prescription, a free testing center, a lab, a rapid test, or a self-test. The goal is to learn more about testing p…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Sponsor: Université de Reims Champagne-Ardenne • Aim: Knowledge-focused
Last updated May 26, 2026 05:28 UTC
-
ER study tests simple video to boost HIV and hepatitis c testing
Knowledge-focused Recruiting nowThis study looks at whether a short, persuasive message—delivered by video or a health counselor—can convince more emergency room patients to get tested for HIV and Hepatitis C. About 2,000 adults who initially said no to testing will take part. The goal is to find an easy, low-c…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: University of South Florida • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC
-
Scientists probe Brain-Immune link in HIV stimulant users to tackle depression
Knowledge-focused Recruiting nowThis study looks at how chronic stress changes brain and immune function in people with HIV who use stimulants. Researchers will use brain scans and interviews to understand these changes, with the goal of finding better ways to treat depression and reduce stimulant use. The stud…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC